The popularity of GLP-1 weight loss drugs might be expanding to our pets. New research is underway for something being called ...

Usage of GLP-1 medications has increased over the past 18 months, with highest adoption among women and adults aged 50-64, ...

The World Health Organization conditionally recommended GLP-1 drugs for obesity. A physician breaks down what you need to ...

While the WHO study saw reports of suicidal thoughts were slightly higher for semaglutide in particular, the warning applies ...

The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat ...

New research suggests that drugs like Ozempic and Wegovy might trigger more than just a slimmer waistline. Many users have ...

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

The World Health Organization has issued its first guidelines for the use of GLP-1s, such as Ozempic, to treat obesity. The ...

The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

GLP-1 drugs like, Ozempic and Wegovy, are in big demand... And they’re going to be more affordable. Two physicians answer the questions we still have about GLP-1s.

Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, ...